REDIPRED

This brand name is authorized in Australia, Hong Kong, New Zealand, South Africa

Active ingredients

The drug REDIPRED contains one active pharmaceutical ingredient (API):

1	Prednisolone UNII IV021NXA9J - PREDNISOLONE SODIUM PHOSPHATE
	Prednisolone is a glucocorticoid which has anti-inflammatory activity. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used for their potent anti-inflammatory effects in disorders of many organ systems.
	Read more about Prednisolone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
REDIPRED Oral solution	MPI, EU: SmPC	Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H02AB06	Prednisolone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8285C
HK	Department of Health Drug Office	50586
NZ	Medicines and Medical Devices Safety Authority	6835
ZA	Health Products Regulatory Authority	41/21.5.1/0243